Received Apr 2, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9PT2F | — |
Infanrix expired dose administration (less than 30 days since expiration); This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa (Infanrix) (batch number 9PT2F, expiry date 10-MAR-2026) for prophylaxis. On 25-MAR-2026, the patient received Infanrix. On 25-MAR-2026, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Infanrix expired dose administration (less than 30 days since expiration)). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.